Marine bacterial secondary metabolites: A treasure house for structurally unique and effective antimicrobial compounds

R Srinivasan, A Kannappan, C Shi, X Lin - Marine Drugs, 2021 - mdpi.com
The prevalence of antimicrobial resistance reduces the effectiveness of antimicrobial drugs
in preventing and treating infectious diseases caused by pathogenic organisms, such as …

Current promising strategies against antibiotic-resistant bacterial infections

J Ye, X Chen - Antibiotics, 2022 - mdpi.com
Infections caused by antibiotic-resistant bacteria (ARB) are one of the major global health
challenges of our time. In addition to developing new antibiotics to combat ARB, sensitizing …

A Smart Photothermal Nanosystem with an Intrinsic Temperature‐Control Mechanism for Thermostatic Treatment of Bacterial Infections

J Wang, B Hao, K Xue, H Fu, M Xiao… - Advanced …, 2022 - Wiley Online Library
Photothermal therapy (PTT) has attracted extensive attention in disease treatments.
However, conventional photothermal systems do not possess a temperature‐control …

A critical review of machine-learning for “multi-omics” marine metabolite datasets

J Manochkumar, AK Cherukuri, RS Kumar… - Computers in Biology …, 2023 - Elsevier
During the last decade, genomic, transcriptomic, proteomic, metabolomic, and other omics
datasets have been generated for a wide range of marine organisms, and even more are …

Paeoniflorin reduce luxS/AI-2 system-controlled biofilm formation and virulence in Streptococcus suis

J Li, Q Fan, M Jin, C Mao, H Zhang, X Zhang, L Sun… - Virulence, 2021 - Taylor & Francis
ABSTRACT Streptococcus suis (S. suis), more specifically serotype 2, is a bacterial
pathogen that threatens the lives of pigs and humans. Like many other pathogens, S. suis …

[HTML][HTML] A new therapeutic strategy for infectious diseases against intracellular multidrug-resistant bacteria

ZJ Wang, YY Zhu, LY Bai, DM Tang, ZS Zhou… - Journal of Controlled …, 2024 - Elsevier
Abstract Bacterial infections result in 7,700,000 deaths per year globally, with intracellular
bacteria causing repeated and resistant infection. No drug is currently licenced for the …

Prospects of exploring the metal–organic framework for combating antimicrobial resistance

SA Polash, T Khare, V Kumar… - ACS Applied Bio …, 2021 - ACS Publications
Infectious diseases are a major public health concern globally. Infections caused by
pathogens with resistance against commonly used antimicrobial drugs or antibiotics (known …

Antibiotics development and the potentials of marine-derived compounds to stem the tide of multidrug-resistant pathogenic bacteria, fungi, and protozoa

JA Nweze, FN Mbaoji, G Huang, Y Li, L Yang, Y Zhang… - Marine Drugs, 2020 - mdpi.com
As the search for new antibiotics continues, the resistance to known antimicrobial
compounds continues to increase. Many researchers around the world, in response to …

The genus Micromonospora as a model microorganism for bioactive natural product discovery

MS Hifnawy, MM Fouda, AM Sayed, R Mohammed… - RSC …, 2020 - pubs.rsc.org
This review covers the development of the genus Micromonospora as a model for natural
product research and the timeline of discovery progress from the classical bioassay-guided …

RETRACTED ARTICLE: Multifaceted role of natural sources for COVID-19 pandemic as marine drugs

MM Rahman, MR Islam, S Shohag, ME Hossain… - … Science and Pollution …, 2022 - Springer
COVID-19, which is caused by the novel severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has quickly spread over the world, posing a global health concern. The …